Literature DB >> 23696934

Genetic distribution and association analysis of DRD2 gene polymorphisms with major depressive disorder in the Chinese Han population.

Mei He1, Hong Yan, Zhao-Xia Duan, Wei Qu, Hai-Yan Gong, Zheng-Li Fan, Jian-Yi Kang, Bing-Cang Li, Jian-Min Wang.   

Abstract

Dopamine D2 receptor is involved in reward-mediating mesocorticolimbic pathways. It plays an important role in major depressive disorder (MDD). Three gene polymorphisms Taq1A, C957T and -141C ins/del, were identified in the DRD2 gene among the Western population. These variants in the DRD2 gene might be associated with the susceptibility of MDD patients through affecting the bioeffects of endogenous dopamine neurotransmission. However, little is known about their occurrence in Chinese population and their association with the susceptibility of patients with major depressive disorder. In this study, a total of 338 unrelated adult Chinese Han population, including 224 healthy volunteers and 114 patients with major depressive disorder, were recruited. DRD2 polymorphisms (Taq1A and -141C ins/del) were detected using restriction fragment length polymorphism (RFLP) analysis and the C957T were detected by sequencing directly. As a result, three polymorphisms were identified in Chinese Han population and all were common SNP. However, we could detect no evidence of genetic association between 3 markers in DRD2 and major depressive disorder in the Chinese Han population. To conclude, this result suggests that Taq1A, C957T and -141C ins/del of DRD2 gene may not be associated with major depressive disorder, also may be the sample sizes too small to allow a meaningful test.

Entities:  

Keywords:  Dopamine D2 receptor; major depressive disorder; polymorphism

Mesh:

Substances:

Year:  2013        PMID: 23696934      PMCID: PMC3657369     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  42 in total

1.  Analysis of SNP profiles in patients with major depressive disorder.

Authors:  Sulev Kõks; Tiit Nikopensius; Kati Koido; Eduard Maron; Signe Altmäe; Evelin Heinaste; Kristel Vabrit; Veronika Tammekivi; Pille Hallast; Ants Kurg; Jakov Shlik; Veiko Vasar; Andres Metspalu; Eero Vasar
Journal:  Int J Neuropsychopharmacol       Date:  2005-06-01       Impact factor: 5.176

Review 2.  The genetics of depression: a review.

Authors:  Douglas F Levinson
Journal:  Biol Psychiatry       Date:  2005-11-21       Impact factor: 13.382

3.  Dopamine and the management of attentional resources: genetic markers of striatal D2 dopamine predict individual differences in the attentional blink.

Authors:  Lorenza S Colzato; Heleen A Slagter; Mischa de Rover; Bernhard Hommel
Journal:  J Cogn Neurosci       Date:  2011-05-12       Impact factor: 3.225

4.  Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

Authors:  E G Jönsson; M M Nöthen; F Grünhage; L Farde; Y Nakashima; P Propping; G C Sedvall
Journal:  Mol Psychiatry       Date:  1999-05       Impact factor: 15.992

5.  Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.

Authors:  Romina Mizrahi; Pablo Rusjan; Ofer Agid; Ariel Graff; David C Mamo; Robert B Zipursky; Shitij Kapur
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

6.  Striatal dopamine mediates the interface between motivational and cognitive control in humans: evidence from genetic imaging.

Authors:  Esther Aarts; Ardi Roelofs; Barbara Franke; Mark Rijpkema; Guillén Fernández; Rick C Helmich; Roshan Cools
Journal:  Neuropsychopharmacology       Date:  2010-05-12       Impact factor: 7.853

7.  D2 dopamine receptor polymorphism and brain regional glucose metabolism.

Authors:  E P Noble; L A Gottschalk; J H Fallon; T L Ritchie; J C Wu
Journal:  Am J Med Genet       Date:  1997-04-18

8.  Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli.

Authors:  Andrea Kobiella; Sabine Vollstädt-Klein; Mira Bühler; Caroline Graf; Hans-Georg Buchholz; Nina Bernow; Igor Y Yakushev; Christian Landvogt; Mathias Schreckenberger; Gerhard Gründer; Peter Bartenstein; Christoph Fehr; Michael N Smolka
Journal:  Hum Brain Mapp       Date:  2010-05       Impact factor: 5.038

9.  Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.

Authors:  Ajna Hamidovic; Andrea Dlugos; Andrew Skol; Abraham A Palmer; Harriet de Wit
Journal:  Exp Clin Psychopharmacol       Date:  2009-12       Impact factor: 3.157

10.  The effects of COMT (Val108/158Met) and DRD4 (SNP -521) dopamine genotypes on brain activations related to valence and magnitude of rewards.

Authors:  Estela Camara; Ulrike M Krämer; Toni Cunillera; Josep Marco-Pallarés; David Cucurell; Wido Nager; Anna Mestres-Missé; Peter Bauer; Rebecca Schüle; Ludger Schöls; Claus Tempelmann; Antoni Rodriguez-Fornells; Thomas F Münte
Journal:  Cereb Cortex       Date:  2009-12-27       Impact factor: 5.357

View more
  3 in total

1.  Dopamine Gene Polymorphism, Biochemical and Oxidative Stress Parameters in Geriatric Population with and Without Depression: A Pilot Study.

Authors:  Raza Abbas Mahdi; Israr Ahmad; Talha Jilani; Jamal Akhtar Ansari; Farzana Mahdi; Abbas Ali Mahdi; Tabrez Jafar
Journal:  Indian J Clin Biochem       Date:  2021-01-03

Review 2.  A Systematic Review of Candidate Genes for Major Depression.

Authors:  Audrone Norkeviciene; Romena Gocentiene; Agne Sestokaite; Rasa Sabaliauskaite; Daiva Dabkeviciene; Sonata Jarmalaite; Giedre Bulotiene
Journal:  Medicina (Kaunas)       Date:  2022-02-14       Impact factor: 2.430

3.  DRD2 and DRD4 genes related to cognitive deficits in HIV-infected adults who abuse alcohol.

Authors:  Karina Villalba; Jessy G Devieux; Rhonda Rosenberg; Jean Lud Cadet
Journal:  Behav Brain Funct       Date:  2015-08-27       Impact factor: 3.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.